Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anticoagulation after EVLT plus great saphenous vein high ligation
ChiCTR-TRC-11002064Phase 4Completed
- Sponsor
- Shanghai Municipal Health Commission
- Start
- Jan 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of low molecular weight heparin calcium in venous stasis (2 arms), sponsored by Shanghai Municipal Health Commission. Primary endpoint: Deep vein thrombosis in lower extremities. Started Jan 2011; status: completed.
02
Drugs
low molecular weight heparin calcium
03
Conditions
venous stasis
Beyond the preview
Go deeper on ChiCTR-TRC-11002064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11002064.